Dana Farber Cancer Institute DFCI - Brookline — Boston, Massachusetts

Dana Farber Cancer Institute DFCI - Brookline is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute DFCI - Brookline has participated in 3 clinical trials.

Therapeutic areas: Uveal Melanoma, Advanced Malignancies, Melanoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute DFCI - Brookline?

Dana Farber Cancer Institute DFCI - Brookline has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute DFCI - Brookline conducted?

Dana Farber Cancer Institute DFCI - Brookline has 3 clinical trials on record. Their work covers Uveal Melanoma, Advanced Malignancies, Melanoma.

Is Dana Farber Cancer Institute DFCI - Brookline accredited by Crixeo Health?

Dana Farber Cancer Institute DFCI - Brookline has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute DFCI - Brookline?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.